University of California San Diego
University of California San Diego
San Diego, California, United States22 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Enlighten Study: The EV-ICD Post Approval Registry | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, cardiovascular disorder, heart disorder | Active, not recruiting | Not stated | 2026-10-08 | NCT06048731 | |
| Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) | PSMA PET-Positive Castration-Resistant Prostate Cancer | Recruiting | Phase 2 | 2026-10-02 | NCT06549465 | |
| TheraSphere With Durvalumab and Tremelimumab for HCC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 2 | 2026-10-01 | NCT05063565 | |
| Pivotal Study of Voro Urologic Scaffold | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urinary Incontinence, Stress, Urination Disorders, Urogenital Diseases, Urological Manifestations, urinary system disorder | Active, not recruiting | Phase 3 | 2026-09-30 | NCT06873581 | |
| Promoting Physical Activity in Older Hispanic/Latino(a) Adults | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Not applicable | 2026-09-21 | NCT06362824 | |
| Women Informed to Screen Depending on Measures of Risk (Wisdom Study) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast cancer, breast carcinoma in situ, breast disorder, breast neoplasm, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, neoplasm, skin disorder | Recruiting | Not applicable | 2026-09-21 | NCT02620852 | |
| Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-09-02 | NCT06795412 | |
| Dupilumab in the Treatment of Pediatric Alopecia Areata | Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 2 | 2026-09-02 | NCT05866562 | |
| Blood Pressure Effects on Cognition and Brain Blood Flow in PD | Hypotension, Orthostatic, Parkinson disease, autonomic nervous system disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, hypotensive disorder, movement disorder, nervous system disorder, neurodegenerative disease, orthostatic intolerance, parkinsonian disorder, primary dysautonomia, synucleinopathy, vascular disorder | Recruiting | Not applicable | 2026-08-07 | NCT05400174 | |
| Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, facioscapulohumeral muscular dystrophy, facioscapulohumeral muscular dystrophy 1, facioscapulohumeral muscular dystrophy 2, frontometaphyseal dysplasia 2, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, progressive muscular dystrophy | Active, not recruiting | Phase 2 | 2026-07-14 | NCT06547216 | |
| Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Enrolling by invitation | Not applicable | 2026-07-08 | NCT06424769 | |
| Early Detection of Advanced Adenomas and Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal adenocarcinoma, colorectal cancer, colorectal neoplasm, colorectal serrated adenocarcinoma, digestive system disorder, digestive system neoplasm, hereditary mixed polyposis syndrome, intestinal disorder, neoplasm, polyp of large intestine, rectal disorder | Recruiting | Not stated | 2026-07-07 | NCT06342440 | |
| P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 1 | 2026-04-24 | NCT04960579 | |
| Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery | Arterial Occlusive Diseases, Coronary Arteriosclerosis, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not stated | 2026-04-17 | NCT03894423 | |
| Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia Patients | Cytopenia, Hemic and Lymphatic Diseases, hematologic disorder, myelodysplastic syndrome | Recruiting | Not stated | 2026-03-25 | NCT07081087 | |
| Outcomes of Urinary Incontinence Treatment in Primary Care: APP Co-Management and Electronic Consult | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urination Disorders, Urogenital Diseases, Urological Manifestations, urinary system disorder | Enrolling by invitation | Not applicable | 2026-03-13 | NCT06040645 | |
| Personalized Antisense Oligonucleotide Therapy for a Single Participant With PRPH2 Mutation Associated With Retinal Dystrophy | eye disorder, inherited retinal dystrophy, retinal degeneration, retinal disorder | Active, not recruiting | Phase 1 / Phase 2 | 2025-09-16 | NCT07177196 | |
| MYTHS - MYocarditis THerapy With Steroids | cardiomyopathy, cardiovascular disorder, heart disorder, myocarditis | Recruiting | Phase 3 | 2025-07-31 | NCT05150704 | |
| ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2025-07-01 | NCT06415487 | |
| American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not stated | 2025-02-25 | NCT02674100 | |
| Real-Time Levodopa Level Monitoring in Parkinson Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not applicable | 2025-02-11 | NCT04735627 | |
| Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2024-08-29 | NCT06577883 |